The FDA’s approval of the first therapy to treat Alzheimer’s Disease in over twenty years brought attention to a not-yet-convened debate of U.S. health care costs and spending, innovation, and return-on-the-investment (as well as “for whom” do the returns accrue). In my latest post for Medecision, I explore different angles on the Aduhelm and Alzheimer’s… Read More »
Dive Brief: The Medicare program overpaid providers more than $ 267 million due to inadequate oversight of patients discharged from an acute care hospital within three days of their admission, according to a new report by the HHS Office of the Inspector General. OIG inspectors combed over more than 89,000 claims filed in fiscal 2016… Read More »
January 17, 2020 Posted By Categories Gary Schwitzer is the founder and publisher of HealthNewsReview.org. He is struggling to be an informed Medicare enrollee. He tweets as @garyschwitzer or @HealthNewsRevu. Since I’ve started writing more about Medicare now that I am more learned and experienced with the program as a person of that age group,… Read More »
The annual Medicare open enrollment period ends soon. America’s seniors have faced a blizzard of dismaying news about the program. Here are some excerpts from newsworthy stories that you should be aware of. Excerpt: “The federal government recently redesigned a digital tool that helps seniors navigate complicated Medicare choices, but consumer advocates say it’s malfunctioning… Read More »
WASHINGTON/NEW YORK (Reuters) – U.S. President Donald Trump, taking aim at “global freeloading,” said on Thursday his administration would seek to lower prescription drug prices by basing what the government’s Medicare program pays for some medications on the lower prices paid in other countries. FILE PHOTO: U.S. President Donald Trump speaks at a campaign rally… Read More »